Clinical Trial Update: Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating megestrol acetate plus rosuvastatin in young women with atypical endometrial hyperplasia has completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia

Drugs mentioned

• Megestrol acetate (megestrol acetate)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Fudan University | Conditions: Atypical Endometrial Hyperplasia | Phase 2, Phase 3 | Status: COMPLETED